These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

646 related items for PubMed ID: 23978642

  • 1. Low-dose salbutamol suppresses airway responsiveness to histamine but not methacholine in subjects with asthma.
    Matsumoto K, Aizawa H, Fukuyama S, Yoshida M, Komori M, Takata S, Koto H, Inoue H.
    Respir Investig; 2013 Sep; 51(3):158-65. PubMed ID: 23978642
    [Abstract] [Full Text] [Related]

  • 2. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    Pulmonary Function and Clinical Respiratory Physiology Committee of Chinese Association of Chest Physicians, Chinese Thoracic Society, Pulmonary Function Group of Respiratory Branch of Chinese Geriatric Society.
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb 12; 47(2):101-119. PubMed ID: 38309959
    [Abstract] [Full Text] [Related]

  • 3. Regular inhaled salbutamol : effect on airway responsiveness to methacholine and adenosine 5'-monophosphate and tolerance to bronchoprotection.
    Jokic R, Swystun VA, Davis BE, Cockcroft DW.
    Chest; 2001 Feb 12; 119(2):370-5. PubMed ID: 11171711
    [Abstract] [Full Text] [Related]

  • 4. The utility of methacholine airway responsiveness measurements in evaluating anti-asthma drugs.
    Inman MD, Hamilton AL, Kerstjens HA, Watson RM, O'Byrne PM.
    J Allergy Clin Immunol; 1998 Mar 12; 101(3):342-8. PubMed ID: 9525450
    [Abstract] [Full Text] [Related]

  • 5. The protective effect of salbutamol inhaled using different devices on methacholine bronchoconstriction.
    Giannini D, Di Franco A, Bacci E, Dente FL, Taccola M, Vagaggini B, Paggiaro P.
    Chest; 2000 May 12; 117(5):1319-23. PubMed ID: 10807817
    [Abstract] [Full Text] [Related]

  • 6. Proof-of-concept evaluation of trough airway hyper-responsiveness following regular racemic or levosalbutamol in genotype-stratified steroid-treated persistent asthmatic patients.
    Anderson WJ, Short PM, Williamson PA, Morrison AE, Palmer C, Tavendale R, Lipworth BJ.
    Clin Sci (Lond); 2014 Jan 01; 126(1):75-83. PubMed ID: 23829494
    [Abstract] [Full Text] [Related]

  • 7. Regular inhaled salbutamol and airway responsiveness to allergen.
    Cockcroft DW, McParland CP, Britto SA, Swystun VA, Rutherford BC.
    Lancet; 1993 Oct 02; 342(8875):833-7. PubMed ID: 8104272
    [Abstract] [Full Text] [Related]

  • 8. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
    Yates DH, Kharitonov SA, Barnes PJ.
    Am J Respir Crit Care Med; 1996 Dec 02; 154(6 Pt 1):1603-7. PubMed ID: 8970342
    [Abstract] [Full Text] [Related]

  • 9. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.
    Haney S, Hancox RJ.
    Respir Res; 2005 Sep 16; 6(1):107. PubMed ID: 16168062
    [Abstract] [Full Text] [Related]

  • 10. The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease.
    Bel EH, Zwinderman AH, Timmers MC, Dijkman JH, Sterk PJ.
    Thorax; 1991 Jan 16; 46(1):9-14. PubMed ID: 1871705
    [Abstract] [Full Text] [Related]

  • 11. Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine.
    Cockcroft DW, Swystun VA, Bhagat R.
    Am J Respir Crit Care Med; 1995 Nov 16; 152(5 Pt 1):1485-9. PubMed ID: 7582281
    [Abstract] [Full Text] [Related]

  • 12. Salbutamol tolerance to bronchoprotection: course of onset.
    Stewart SL, Martin AL, Davis BE, Cockcroft DW.
    Ann Allergy Asthma Immunol; 2012 Dec 16; 109(6):454-7. PubMed ID: 23176887
    [Abstract] [Full Text] [Related]

  • 13. Airway reactivity is a determinant of bronchodilator responsiveness after methacholine-induced bronchoconstriction.
    Parker AL.
    J Asthma; 2004 Sep 16; 41(6):671-7. PubMed ID: 15584317
    [Abstract] [Full Text] [Related]

  • 14. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
    Cheung D, Timmers MC, Zwinderman AH, Bel EH, Dijkman JH, Sterk PJ.
    N Engl J Med; 1992 Oct 22; 327(17):1198-203. PubMed ID: 1357550
    [Abstract] [Full Text] [Related]

  • 15. Detrimental effects of albuterol on airway responsiveness requires airway inflammation and is independent of β-receptor affinity in murine models of asthma.
    Lundblad LK, Rinaldi LM, Poynter ME, Riesenfeld EP, Wu M, Aimi S, Barone LM, Bates JH, Irvin CG.
    Respir Res; 2011 Mar 07; 12(1):27. PubMed ID: 21385381
    [Abstract] [Full Text] [Related]

  • 16. Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: dose response.
    Bhagat R, Swystun VA, Cockcroft DW.
    J Allergy Clin Immunol; 1996 Jan 07; 97(1 Pt 1):47-52. PubMed ID: 8568137
    [Abstract] [Full Text] [Related]

  • 17. Comparative protective effect of the inhaled beta 2-agonist salbutamol (albuterol) on bronchoconstriction provoked by histamine, methacholine, and adenosine 5'-monophosphate in asthma.
    Phillips GD, Finnerty JP, Holgate ST.
    J Allergy Clin Immunol; 1990 Apr 07; 85(4):755-62. PubMed ID: 2182697
    [Abstract] [Full Text] [Related]

  • 18. Effect of an inhaled thromboxane mimetic (U46619) on airway function in human subjects.
    Jones GL, Saroea HG, Watson RM, O'Byrne PM.
    Am Rev Respir Dis; 1992 Jun 07; 145(6):1270-4. PubMed ID: 1595990
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.